Management of Acute Stroke Patients on Treatment with New Oral Anticoagulants: Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry

Brief description of study

The purpose of this study is to improve the treatment and management of patients with either AIS (Acute Ischemic Stroke) or ICH (Intracranial Hemorrhage) on anticoagulant therapy. We are looking to enroll patients who have recently been admitted to the hospital to receive treatment for your stroke. The total duration of participation in this study will be about 12 months. Your participation will consist of completing a baseline survey and telephone interviews at 3 and 6 months after your enrollment to ask questions about your ability to perform common everyday activities, medications you are taking, medical care that you have received, symptoms you are having related to your stroke, and how your feeling.


Clinical Study Identifier: s16-00552
ClinicalTrials.gov Identifier: NCT02200614
Principal Investigator: Koto Ishida
Currently Recruiting

Contact the research team to learn more about this study.


By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.